PL2958558T3 - Sposoby i kompozycje do leczenia białaczki - Google Patents

Sposoby i kompozycje do leczenia białaczki

Info

Publication number
PL2958558T3
PL2958558T3 PL14754927T PL14754927T PL2958558T3 PL 2958558 T3 PL2958558 T3 PL 2958558T3 PL 14754927 T PL14754927 T PL 14754927T PL 14754927 T PL14754927 T PL 14754927T PL 2958558 T3 PL2958558 T3 PL 2958558T3
Authority
PL
Poland
Prior art keywords
compositions
methods
treating leukemia
leukemia
treating
Prior art date
Application number
PL14754927T
Other languages
English (en)
Inventor
Sheng-Yung Liu
Wu-Che Wen
Chih-Ming Chen
Original Assignee
Golden Biotechnology Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golden Biotechnology Corporation filed Critical Golden Biotechnology Corporation
Publication of PL2958558T3 publication Critical patent/PL2958558T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/28—Quinones containing groups having oxygen atoms singly bound to carbon atoms with monocyclic quinoid structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL14754927T 2013-02-20 2014-02-20 Sposoby i kompozycje do leczenia białaczki PL2958558T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361767211P 2013-02-20 2013-02-20
EP14754927.3A EP2958558B1 (en) 2013-02-20 2014-02-20 Methods and compositions for treating leukemia
PCT/US2014/017285 WO2014130619A2 (en) 2013-02-20 2014-02-20 Methods and compositions for treating leukemia

Publications (1)

Publication Number Publication Date
PL2958558T3 true PL2958558T3 (pl) 2018-12-31

Family

ID=51391965

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14754927T PL2958558T3 (pl) 2013-02-20 2014-02-20 Sposoby i kompozycje do leczenia białaczki

Country Status (16)

Country Link
US (1) US9403747B2 (pl)
EP (1) EP2958558B1 (pl)
JP (1) JP6501123B2 (pl)
KR (1) KR102054038B1 (pl)
CN (2) CN105246470A (pl)
AU (1) AU2014218938B2 (pl)
BR (1) BR112015019924A2 (pl)
CA (1) CA2901745A1 (pl)
DK (1) DK2958558T3 (pl)
ES (1) ES2687286T3 (pl)
HK (2) HK1219884A1 (pl)
MX (1) MX2015010728A (pl)
PL (1) PL2958558T3 (pl)
TW (1) TWI597061B (pl)
WO (1) WO2014130619A2 (pl)
ZA (1) ZA201506330B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017219871B2 (en) * 2016-02-17 2020-09-03 Golden Biotechnology Corporation Compositions and methods for treating liver cancer
CN109195606A (zh) * 2016-05-13 2019-01-11 国鼎生物科技股份有限公司 用于治疗晚期非小细胞肺癌的方法和组合物
TWI601535B (zh) * 2016-06-23 2017-10-11 台灣利得生物科技股份有限公司 牛樟段木栽培牛樟芝子實體及固態培養菌絲體水及乙醇萃取物之組合物應用於抗癌藥輔助劑
CN107540641A (zh) * 2016-06-29 2018-01-05 彭朗 一种新的有机酯类化合物及其制备方法和医药用途
US10314241B1 (en) * 2016-09-14 2019-06-11 T. Scott Dunn Airborne vegetation cutting assembly
US11406605B2 (en) * 2017-12-20 2022-08-09 Golden Biotechnology Corporation Therapeutic compositions for treating pancreatic cancer
CN113795258B (zh) * 2019-02-25 2024-04-16 吉亚生技控股股份有限公司 抑制病毒感染的方法及组合物
US11548069B2 (en) 2019-05-20 2023-01-10 Wisconsin Alumni Research Foundation Three-dimensional printer laminating fusible sheets
CN121673157A (zh) * 2026-02-09 2026-03-17 赣州市人民医院 一种蒽醌化合物及其提取方法和应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3993073A (en) 1969-04-01 1976-11-23 Alza Corporation Novel drug delivery device
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4069307A (en) 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US3731683A (en) 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US3996934A (en) 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
BE795384A (fr) 1972-02-14 1973-08-13 Ici Ltd Pansements
US3921636A (en) 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US3972995A (en) 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4060084A (en) 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4201211A (en) 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
JPS5562012A (en) 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
US4230105A (en) 1978-11-13 1980-10-28 Merck & Co., Inc. Transdermal delivery of drugs
US4291015A (en) 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
US5633009A (en) 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
US5665378A (en) 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US5905089A (en) * 1997-04-14 1999-05-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Use of sesquiterpene lactones for treatment of severe inflammatory disorders
US5869090A (en) 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
US20070287672A1 (en) * 2004-04-20 2007-12-13 Donald Creighton Macromolecular Gsh-Activiated Glyoxylase I Inhibitors
MX2007003790A (es) * 2004-09-30 2007-05-24 Ariad Gene Therapeutics Inc Metodo de tratamiento.
CN101343247B (zh) * 2007-07-12 2011-01-19 国鼎生物科技股份有限公司 牛樟芝的环己烯酮萃取物
TW200918498A (en) * 2007-10-19 2009-05-01 Golden Biotechnology Corp Novel compound isolated from Antrodia camphorate extracts
TWI389699B (zh) * 2009-02-13 2013-03-21 高雄醫學大學 用於誘導細胞凋亡之樟芝子實體乙醇萃取物及其製備方法
TW201102075A (en) * 2009-07-09 2011-01-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea that suppresses growth of tumor cell of pancreatic cancer
TW201109013A (en) * 2009-09-09 2011-03-16 Golden Biotechnology Corp Cyclohexenone chemical compounds of Antrodia cinnamomea for suppressing the growth of the Lymphoma tumor cell
EP2329816B1 (en) * 2009-11-26 2016-04-13 National Taiwan University An anti-cancer active substance from antrodia camphorata, method for preparing the same and use thereof
CN102232942B (zh) * 2010-05-06 2013-03-27 国鼎生物科技股份有限公司 用于抑制淋巴癌肿瘤细胞生长的牛樟芝环己烯酮化合物
US8309611B2 (en) * 2010-09-20 2012-11-13 Golden Biotechnology Corporation Methods and compositions for treating lung cancer
AU2011336882A1 (en) * 2010-11-24 2013-06-20 Exelixis, Inc. Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
TWI444189B (zh) * 2011-05-31 2014-07-11 財團法人台灣基督長老教會馬偕紀念社會事業基金會馬偕紀念醫院 羊毛甾醇-8,24-二烯-3β,15α,21-三醇抑制腫瘤細胞生長之用途
EP2717865A4 (en) * 2011-06-10 2014-11-12 Golden Biotechnology Corp METHOD AND COMPOSITIONS FOR TREATING BRAIN CANCER
TWI484954B (zh) * 2011-10-11 2015-05-21 New Bellus Entpr Co Ltd 用於治療癌症之醫藥組合物
WO2014151304A1 (en) * 2013-03-15 2014-09-25 Golden Biotechnology Corporation Therapeutic methods and compositions utilizing cyclohexenone compounds

Also Published As

Publication number Publication date
ES2687286T3 (es) 2018-10-24
TWI597061B (zh) 2017-09-01
BR112015019924A2 (pt) 2017-07-18
JP2016509058A (ja) 2016-03-24
ZA201506330B (en) 2016-10-26
WO2014130619A2 (en) 2014-08-28
KR20150120424A (ko) 2015-10-27
CA2901745A1 (en) 2014-08-28
US9403747B2 (en) 2016-08-02
DK2958558T3 (en) 2018-09-24
HK1219884A1 (zh) 2017-04-21
CN105246470A (zh) 2016-01-13
US20150025135A1 (en) 2015-01-22
KR102054038B1 (ko) 2019-12-09
EP2958558B1 (en) 2018-06-13
WO2014130619A3 (en) 2014-10-16
JP6501123B2 (ja) 2019-04-17
AU2014218938A1 (en) 2015-09-10
HK1255453A1 (zh) 2019-08-16
TW201446240A (zh) 2014-12-16
MX2015010728A (es) 2016-04-11
EP2958558A4 (en) 2016-08-10
CN108309961A (zh) 2018-07-24
EP2958558A2 (en) 2015-12-30
AU2014218938B2 (en) 2018-12-06

Similar Documents

Publication Publication Date Title
IL281058B1 (en) Compositions and methods for treating anemia
IL273205A (en) Preparations and methods
GB2533892B (en) Compositions and methods
IL245281A0 (en) Methods and preparations for the treatment of cancer
IL246023B (en) Methods and preparations for the treatment of age-related conditions
SMT201900635T1 (it) Composizioni e metodi di attivazione della segnalazione dipendente dallo "stimolatore di geni interferone"
IL245778B (en) Methods and preparations for the treatment of hemophilia
SG10201707319UA (en) Compositions and methods for treating mpsi
ZA201505390B (en) Compositions and methods for treating pests
GB201308072D0 (en) Compositions and methods
ZA201506330B (en) Methods and compositions for treating leukemia
EP3052102A4 (en) Compositions and methods for treating cancers
GB201305813D0 (en) Compositions and methods
IL239680B (en) Preparations and methods for polynucleotide transfection
SG11201510300RA (en) Compositions and methods for treating skin
IL243022B (en) Compositions and methods for post-harvest treatment
GB201302475D0 (en) Compositions and methods for treating biofilms
GB201302474D0 (en) Compositions and methods for treating biofilms
GB201302472D0 (en) Compositions and methods for treating biofilms
GB201322617D0 (en) Methods and compositions
GB201312393D0 (en) Compositions and Methods
GB201304271D0 (en) Composition and apparatus